Fundz

Riverside Partners' Portfolio Company Syner-G Acquires Impact

PRIVATEFeb 01, 2022

Acquiring Company

Syner-G BioPharma Group

Acquired Company

Impact Pharmaceutical Services

ManufacturingManufacturingHealth Care

Description

Syner-G BioPharma Group ("Syner-G" or the "Company"), a leading provider of Chemistry, Manufacturing, and Controls ("CMC") technical, regulatory, and compliance consulting services to pharmaceutical and biotechnology clients, today announced the acquisition of Impact Pharmaceutical Services ("IMPACT"). Based in Research Triangle Park, NC, IMPACT supports the outsourced medical writing, regulatory strategy, and regulatory publishing and submission needs of biotech and pharma companies from pre-IND through post-marketing of drugs and biologics. Syner-G is a portfolio company of Riverside Partners, a Boston-based private equity firm.

Quick answer

Syner-G BioPharma Group is acquiring Impact Pharmaceutical Services, announced February 1, 2022.

How much did Syner-G BioPharma Group pay for Impact Pharmaceutical Services?
The deal value was not disclosed.
What does Syner-G BioPharma Group do?
Based in Boston, MA, Syner-G is a leading provider of customized science and risk-based CMC and regulatory solutions and services, supporting pharmaceutical and biotechnology companies across small molecule, large..

Source: Fundz verified event record.

Other recent acquisitions in Manufacturing and Manufacturing

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Syner-G BioPharma Group, and when

When Syner-G BioPharma Group changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Syner-G BioPharma Group raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Syner-G BioPharma Group, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Syner-G BioPharma Group. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Syner-G BioPharma Group

About

Based in Boston, MA, Syner-G is a leading provider of customized science and risk-based CMC and regulatory solutions and services, supporting pharmaceutical and biotechnology companies across small molecule, large molecule, and cell and gene therapy products. With its high customer retention, Syner-G oversees all aspects of CMC and regulatory services throughout the drug development process and post-commercialization. For more information, visit www.synergbiopharma.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Syner-G BioPharma Group makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Syner-G BioPharma Group's next move

Learn about Strategic plan

Frequently asked

Who acquired Impact Pharmaceutical Services?

Impact Pharmaceutical Services was acquired by Syner-G BioPharma Group. The deal was reported on February 1, 2022. Syner-G BioPharma Group is privately held and operates in Manufacturing.

When did Syner-G BioPharma Group acquire Impact Pharmaceutical Services?

Syner-G BioPharma Group's acquisition of Impact Pharmaceutical Services was reported on February 1, 2022. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Impact Pharmaceutical Services do?

Based in Research Triangle Park, NC, IMPACT specializes in medical writing and quality control, drug development consulting, regulatory affairs, regulatory operations, and project and program management for the pharmaceutical and biotech sector. It is privately held, operating in Manufacturing.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.